Home
>
US Stocks
>
CytomX Therapeutics Inc
CytomX Therapeutics Inc
CTMX

CytomX Therapeutics Inc

$5.020.59%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.01
Today Low/High
4.98 / 5.06
52 Week Low/High
$4.73 / $10.05
P/E ratio
-4.9623
Market Cap
$318.62M

Company Details

CytomX is a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies. CytomX is developing a novel class of investigational conditionally activated antibody therapeutics, based on its Probody® technology platform, for the treatment of cancer. CytomX has strategic drug discovery and development collaborations with AbbVie, Amgen, Astellas, and Bristol Myers Squibb.
Organisation
CytomX Therapeutics Inc
Headquaters
South San Francisco, California, US
Employees
145
Industry
Health Technology
CEO
Sean McCarthy

Discover more

Frequently Asked Questions

What is CytomX Therapeutics Inc share price today

Can Indians buy CytomX Therapeutics Inc shares?

How can I buy CytomX Therapeutics Inc shares from India?

Can Fractional shares of CytomX Therapeutics Inc be purchased?

What are the documents required to start investing in CytomX Therapeutics Inc stocks?

We are a SEBI registered investement advisor